Director and Chief Executive Officer at Beleave Inc. (CSE:BE)(OTC:BLEVF)(FRA:4B9), Dr. Roger Ferreira, recently filed with SEDI concerning his purchase of Beleave shares. Although this specific case of insider buying represents an extremely small fraction of Beleave's 31 million shares outstanding, it's still worth taking note of. Combined with other market indicators and/or additional research, awareness of when insiders are buying or selling can help you stay on the right side of the market.
Insider Buying by Director and CEO, Dr. Roger Ferreria
On August 1st, Dr. Roger Ferreria bought 5,000 shares of Beleave Inc. at a weighted average price of $1.20 CAD/share. This represents a total investment of $6,000 CAD (~$4782 USD). Following this purchase, Dr. Ferreria is the beneficial owner of 715,540 shares of Beleave.
For more information on Beleave, be sure to check out the company's marijuana stock profile in our Canadian licensed producer database.
Be sure to subscribe to one or more of our free newsletters (especially our Canadian licensed producer newsletter) so you never miss an important marijuana industry update.
Don't be a stranger, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
Now Read: Beleave Inc. Becomes 44th Licensed Producer!
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.